Aktie A086450 DONGKOOK PHARMACEUTICAL CO., LTD.
Zu einer Liste hinzufügen
Um diese Funktionalität nutzen zu können, müssen Sie Mitglied sein
EinloggenRegistrieren

Andere Sprachen DongKook Pharmaceutical Co., Ltd.

Aktien

A086450

KR7086450004

A086450

Schlusskurs Korea S.E.
Andere Börsenplätze
 00:00:00 24.05.2024 		% 5 Tage % 1. Jan.
18’720 KRW +6.97% Intraday Chart für DongKook Pharmaceutical Co., Ltd. +5.76% +15.84%
16.05. DongKook Pharmaceutical Co., Ltd. meldet Ergebnis für das erste Quartal bis zum 31. März 2024 CI
14.03. DongKook Pharmaceutical Co., Ltd. meldet Ergebnis für das am 31. Dezember 2023 endende Geschäftsjahr CI

Andere Sprachen

Suchen
Ergebnisse ansehen
Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!
100% kostenlose Registrierung
DongKook Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024
DongKook Pharmaceutical Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023
DongKook Pharmaceutical Co., Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023
DongKook Pharmaceutical Co., Ltd. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023
DongKook Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023
DongKook Pharmaceutical Co., Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022
DongKook Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2022
Eight South Korean Firms to Donate $2.4 Million Worth of Medicine to Ukraine
DongKook Pharmaceutical Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2021
DongKook Pharmaceutical Co., Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2021
YJM Games Co., Ltd. announced that it has received KRW 7.5 billion in funding from HisStory Investment Management, DongKook Pharmaceutical Co., Ltd.
YJM Games Co., Ltd. announced that it expects to receive KRW 7.5 billion in funding from HisStory Investment Management, DongKook Pharmaceutical Co., Ltd., and other investors
Hanchang Corporation announced that it has received KRW 5 billion in funding from MAGNA Investment Co., Ltd., Axis Investment Co., Ltd., DongKook Pharmaceutical Co., Ltd., Jinhaksa Corporation
Hanchang Corporation announced that it expects to receive KRW 5 billion in funding from MAGNA Investment Co., Ltd., Axis Investment Co., Ltd., DongKook Pharmaceutical Co., Ltd., Jinhaksa Corporation
DongKook Pharmaceutical Co., Ltd. announced that it has received KRW 10.0000516 billion in funding
DongKook Pharmaceutical Co., Ltd. announced that it expects to receive KRW 10.0000516 billion in funding
GS Instruments Co. Ltd. announced that it has received KRW 3 billion in funding from DONGKOOK Pharmaceutical Co., Ltd., Unione Communications Co., Ltd., GS Teletech Co., Ltd., and other investors.
GS Instruments Co. Ltd. announced that it expects to receive KRW 3 billion in funding from DONGKOOK Pharmaceutical Co., Ltd., Unione Communications Co., Ltd., GS Teletech Co., Ltd., and other investors.
DONGKOOK Pharmaceutical Co., Ltd.'s Equity Buyback announced on March 13, 2015 has expired.
DONGKOOK Pharmaceutical Co., Ltd.(KOSDAQ:A086450) added to Russell Global Index
Keine Ergebnisse zu dieser Suche
Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Filter

Suchen

Datum der Veröffentlichung

Vom

Bis

  1. Börse
  2. Aktien
  3. A086450 Aktie
  4. Nachrichten DongKook Pharmaceutical Co., Ltd.
  5. Andere Sprachen